The pyrogenicity of lipopolysaccharide-contaminated human albumin solutions
Dressel, H.; Eckardt, B.; Hoffmann, B.; Odebrecht, W.
Die Pharmazie 46(2): 141-143
1991
ISSN/ISBN: 0031-7144 PMID: 1852766 Document Number: 386550
Document emailed within 1 workday
Related Documents
2000: Indications for the use of human albumin solutions: an expert report. Human albumin expert group Schweizerische Medizinische Wochenschrift 130(14): 516-522Carsin, H. 1997: Human albumin solutions in the treatment of burned patients. Current indications Presse Medicale 26(10): 474-476
Savić, J.; Pantelić, D.; Vujnov, S.; Zunić, O. 1977: Study on the efficacy of dextran, gelatin and human albumin solutions as plasma substitutes Vojnosanitetski Pregled 34(3): 197-203
Pakzad, I.; Rezaee, A.; Rasaee, M.J.; Hossieni, A.Z.; Tabbaraee, B.; Kazemnejad, A. 2010: Protection of BALB/C mice against Brucella abortus 544 challenge by vaccination with combination of recombinant human serum albumin-l7/l12 (Brucella abortus ribosomal protein) and lipopolysaccharide Roumanian Archives of Microbiology and Immunology 69(1): 5-12
Lang, W.R. 1971: Contaminated antiseptic solutions New Zealand Medical Journal 73(466): 172
Magnuson, D.K.; Weintraub, A.; Pohlman, T.H.; Maier, R.V. 1989: Human endothelial cell adhesiveness for neutrophils, induced by Escherichia coli lipopolysaccharide in vitro, is inhibited by Bacteroides fragilis lipopolysaccharide Journal of Immunology 143(9): 3025-3030
Azhyts'kyĭ, H.I.; Bélianova, L.I.; Malyĭ, K.D. 1975: Study of the amino acid composition of albumin fractions obtained from human serum albumin Ukrains'kyi Biokhimichnyi Zhurnal 47(1): 94-100
Gros, G. 1972: Increased diffusion of CO 2 in albumin solutions Pflugers Archiv: European Journal of Physiology 332: Suppl 332:r8
Vasil'ev, B.K.; Shekhovtsova, M.F.; Ermak, I.M.; Gladkikh, R.V.; Solov'eva, T.F. 1985: Study of a lipopolysaccharide-protein complex from Yersinia pseudotuberculosis in aqueous solutions by light scattering Biofizika 30(6): 981-984
Polyanichko, A.M.; Mikhailov, N.V.; Romanov, N.M.; Baranova, Y.G.; Chikhirzhina, E.V. 2016: Intermolecular Interactions in the Solutions of Serum Albumin Tsitologiia 58(9): 707-713
Pozdniakov, V.A.; Gel'fand, E.M.; Foĭgel', G.A. 1971: Desiccation of albumin solutions in stainless steel trays Problemy Gematologii i Perelivaniia Krovi 16(12): 53-55
Toledo-Pereyra, L.H.; Mittal, V.K.; Gordon, D.A. 1988: Albumin-augmented crystalloid or hyperosmolar colloid solutions for clinical pancreas preservation Transplantation Proceedings 20(5): 1021-1022
Cooperman, A.M.; Woods, J.E.; Holley, K.E.; McIlrath, D.C. 1971: Twenty-four-hour perfusion and storage of canine kidneys with albumin and electrolyte solutions Mayo Clinic Proceedings 46(3): 193-196
Turov, V.V.; Bakaĭ, E.A.; Turov, A.V.; Kornilov, M.I. 1990: Study of alcohol binding with serum albumin by NMR spectra of frozen aqueous solutions Biofizika 35(5): 770-774
Amend, D.F.; Fender, D.C. 1976: Uptake of bovine serum albumin by rainbow trout from hypersmotic solutions: a model for vaccinating fish Science 192(4241): 793-794
Bunk, A.; Dapper, F.; Hata, H.; Neuhof, H.; Hehrlein, F.W. 1993: Experimental studies of the influence of priming solutions on the systemic activation of complement during cardiopulmonary bypass: comparison between the use of albumin, hydroxyethyl starch and HWA-138 Journal of Cardiovascular Surgery 34(2): 115-122
Kelly, M.E.; Behrman, S.W. 2002: The safety and efficacy of prosthetic hernia repair in clean-contaminated and contaminated wounds American Surgeon 68(6): 524-528; Discussion: 528-529
Shimauchi, H.; Ogawa, T.; Uchida, H.; Yoshida, J.; Ogoh, H.; Nozaki, T.; Okada, H. 1996: Splenic B-cell activation in lipopolysaccharide-non-responsive C3H/HeJ mice by lipopolysaccharide of Porphyromonas gingivalis Experientia 52(9): 909-917
Pearson, F.C. 1985: A comparison of the pyrogenicity of environmental endotoxins and lipopolysaccharides Progress in Clinical and Biological Research 189: 251-265
Benesová, O. 1970: Repeated use of rabbits for pharmacopoeial pyrogenicity test Ceskoslovenska Farmacie 19(6): 207-209